• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1型人类免疫缺陷病毒在T淋巴细胞系中的正向突变率

Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line.

作者信息

Mansky L M

机构信息

McArdle Laboratory for Cancer Research, University of Wisconsin Medical School, Madison 53706, USA.

出版信息

AIDS Res Hum Retroviruses. 1996 Mar 1;12(4):307-14. doi: 10.1089/aid.1996.12.307.

DOI:10.1089/aid.1996.12.307
PMID:8906991
Abstract

An in vivo assay was previously developed for detecting forward mutations in human immunodeficiency virus type 1 (HIV-1) in a single cycle of replication. This system uses the lacZalpha peptide gene as a reporter for mutations, and allows for the rates and types of mutations that occur to be determined. The forward mutation rate for HIV-1 in HeLa cells was found to be 3 x 10(-5) mutations per target base pair per cycle. To test whether the mutation rate was influenced by cell type, the mutation rate of HIV-1 in CEM-A cells, a T lymphoid cell line, was determined. The mutation rate of HIV-1 reverse transcription in CEM-A cells was found to be 4 x 10(-5) mutations per target base pair per cycle. The number and types of mutations observed were similar to that in HeLa cells. Specifically, base substitution mutations predominated, and G-to-A transition mutations were the most common base substitution. G-to-A hypermutants were also characterized. The difference in HIV-1 mutation rate between HeLa and CEM-A cells was not significant, indicating that the accuracy of HIV-1 reverse transcription is comparable in both the HeLa and CEM-A cell lines.

摘要

先前已开发出一种体内测定法,用于在单个复制周期中检测1型人类免疫缺陷病毒(HIV-1)的正向突变。该系统使用lacZα肽基因作为突变的报告基因,并能够确定发生的突变率和突变类型。发现HIV-1在HeLa细胞中的正向突变率为每个靶碱基对每周期3×10⁻⁵个突变。为了测试突变率是否受细胞类型影响,测定了HIV-1在T淋巴细胞系CEM-A细胞中的突变率。发现HIV-1在CEM-A细胞中的逆转录突变率为每个靶碱基对每周期4×10⁻⁵个突变。观察到的突变数量和类型与HeLa细胞中的相似。具体而言,碱基替换突变占主导,G到A的转换突变是最常见的碱基替换。还对G到A的超突变体进行了表征。HeLa细胞和CEM-A细胞之间HIV-1突变率的差异不显著,表明HIV-1逆转录的准确性在HeLa细胞系和CEM-A细胞系中相当。

相似文献

1
Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line.1型人类免疫缺陷病毒在T淋巴细胞系中的正向突变率
AIDS Res Hum Retroviruses. 1996 Mar 1;12(4):307-14. doi: 10.1089/aid.1996.12.307.
2
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.人类免疫缺陷病毒1型在体内的突变率低于根据纯化逆转录酶保真度所预测的突变率。
J Virol. 1995 Aug;69(8):5087-94. doi: 10.1128/JVI.69.8.5087-5094.1995.
3
The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene.1型人类免疫缺陷病毒的突变率受vpr基因影响。
Virology. 1996 Aug 15;222(2):391-400. doi: 10.1006/viro.1996.0436.
4
Mutations in the vpu, env, and nef genes of a syncytium-inducing variant of HIV type 1 JR-CSF that infects a range of T cell lines.
AIDS Res Hum Retroviruses. 1996 Mar 1;12(4):347-50. doi: 10.1089/aid.1996.12.347.
5
In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy.1型人类T细胞白血病病毒逆转录准确性的体内分析。
J Virol. 2000 Oct;74(20):9525-31. doi: 10.1128/jvi.74.20.9525-9531.2000.
6
Sequence evolution and escape from specific immune pressure of an HIV-1 Rev epitope with extensive sequence similarity to human nucleolar protein 6.与人类核仁蛋白6具有广泛序列相似性的HIV-1 Rev表位的序列进化及对特定免疫压力的逃逸
Tissue Antigens. 2012 Mar;79(3):174-85. doi: 10.1111/j.1399-0039.2012.01837.x.
7
Constitutive expression of chimeric neo-Rev response element transcripts suppresses HIV-1 replication in human CD4+ T lymphocytes.嵌合型新Rev反应元件转录本的组成型表达可抑制HIV-1在人CD4+T淋巴细胞中的复制。
Hum Gene Ther. 1994 Feb;5(2):193-201. doi: 10.1089/hum.1994.5.2-193.
8
Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.Tat-人类免疫缺陷病毒的感染与复制:原代及长期人类淋巴细胞中LTR和tat突变的遗传分析
Virology. 1995 Aug 1;211(1):157-69. doi: 10.1006/viro.1995.1388.
9
A new cell-based assay for measuring the forward mutation rate of HIV-1.
J Virol Methods. 2005 Mar;124(1-2):95-104. doi: 10.1016/j.jviromet.2004.11.010. Epub 2004 Dec 28.
10
Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication.HIV-1 复制单轮中产生的突变的性质、位置和频率。
J Virol. 2010 Oct;84(19):9864-78. doi: 10.1128/JVI.00915-10. Epub 2010 Jul 21.

引用本文的文献

1
How to recover from a bad start: adaptation of HIV-1 transcription start site mutants during serial passaging in culture.如何从糟糕的开端中恢复:HIV-1转录起始位点突变体在培养中的连续传代过程中的适应性
J Virol. 2025 Jun 17;99(6):e0015925. doi: 10.1128/jvi.00159-25. Epub 2025 May 7.
2
Next-Generation Sequencing Methods to Determine the Accuracy of Retroviral Reverse Transcriptases: Advantages and Limitations.用于确定逆转录病毒逆转录酶准确性的新一代测序方法:优势与局限
Viruses. 2025 Jan 26;17(2):173. doi: 10.3390/v17020173.
3
SARS-CoV-2 drug resistance and therapeutic approaches.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的耐药性及治疗方法。
Heliyon. 2025 Jan 15;11(2):e41980. doi: 10.1016/j.heliyon.2025.e41980. eCollection 2025 Jan 30.
4
HIV-1 usurps transcription start site heterogeneity of host RNA polymerase II to maximize replication fitness.HIV-1 利用宿主 RNA 聚合酶 II 的转录起始位点异质性来最大限度地提高复制适应性。
Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2305103120. doi: 10.1073/pnas.2305103120. Epub 2023 May 30.
5
Antigen-specific and cross-reactive T cells in protection and disease.抗原特异性和交叉反应性 T 细胞在保护和疾病中的作用。
Immunol Rev. 2023 Jul;316(1):120-135. doi: 10.1111/imr.13217. Epub 2023 May 20.
6
Global landscape of SARS-CoV-2 mutations and conserved regions.SARS-CoV-2 突变和保守区域的全球景观。
J Transl Med. 2023 Feb 25;21(1):152. doi: 10.1186/s12967-023-03996-w.
7
Emerging and Re-Emerging Viral Infections: An Indian Perspective.新发和再发病毒感染:印度视角
Cureus. 2022 Oct 8;14(10):e30062. doi: 10.7759/cureus.30062. eCollection 2022 Oct.
8
Molecular Biology and Diversification of Human Retroviruses.人类逆转录病毒的分子生物学与多样化
Front Virol. 2022;2. doi: 10.3389/fviro.2022.872599. Epub 2022 Jun 2.
9
Role of artificial intelligence in peptide vaccine design against RNA viruses.人工智能在针对RNA病毒的肽疫苗设计中的作用。
Inform Med Unlocked. 2021;26:100768. doi: 10.1016/j.imu.2021.100768. Epub 2021 Oct 23.
10
Development of a User-Friendly Pipeline for Mutational Analyses of HIV Using Ultra-Accurate Maximum-Depth Sequencing.开发一种使用超高精确最大深度测序进行 HIV 突变分析的用户友好型流程。
Viruses. 2021 Jul 11;13(7):1338. doi: 10.3390/v13071338.